Pluristem Therapeutics Leadership

Q: Who is the founder of Pluristem Therapeutics?

Shai Meretzki founded Pluristem Therapeutics.

Zippia score 3.7

Pluristem Therapeutics executives

Here are further demographic highlights of the leadership team:

The Pluristem Therapeutics executive team is 59% female and 41% male.
63% of the management team is White.
8% of Pluristem Therapeutics management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Pluristem Therapeutics?

Share your experience

Rate Pluristem Therapeutics' leadership communication with employees.

Name & TitleBio

Shai Meretzki

Founder

Yaky Yanay

Board Member

CEO and President at Pluristem Therapeutics (Nasdaq, TASE: PSTI) - Spearheading the development of placenta-based regenerative therapies for unmet medical needs.

Mr. Zami Aberman

Executive Chairman

Mr. Zami Aberman is a Chairman and Chief Executive Officer at PLURISTEM THERAPEUTICS INC and is based in Israel.

Doron Shorrer Mba, Cpa

Board Member

Doron Shorrer MBA, CPA is a Chairman & Chief Executive Officer at PLURISTEM THERAPEUTICS INC and is based in Aig Israel Insurance Co. Ltd..

Maital Shemesh-Rasmussen

Board Member

Chen Franco-Yehuda

CFO

Highly-driven and professional business-oriented Chief Financial Officer with a successful background in leading and managing corporate finance and organizational strategy.

Bring a hands-on approach and proven ability to motivate people, lead teams and oversee cross organizational processes. Extensive management skills in public and private fundraising, resource and financial planning, PR and marketing communications, strategic collaborations and Information Technology (IT).

Achievements:

- Led successful capital raisings in the U.S. and Israel.

- Generated and negotiated high-level strategic deals such as the EIB 50M EURO financing

- Successfully managed multi-million-dollar company budgets

- Developed and implemented financial controls and processes significantly improving financial efficiency

- Planned, implemented and coordinated new IT infrastructure.

Expertise:

Financial Strategy, Investor Relations (IR), Capital Raising, IPO, Business Development, Fundraising, Financial Accounting, People Management, Tax Accounting, Auditing, Budget, Management, Treasury, Risk Management, Cash Flow, IT Management, Contracts, Forecasting, IFRS, Tax Management, Corporate Finance, US GAAP, Financial Reporting, CPA, Due Diligence, Financial Modeling, Business Intelligence, Payroll and Benefits, Cashflow Analysis.

Efrat Livne-Hadass

VP Human Resources

Isaac Braun

Board Member

Lior Raviv

VP Operations & Development

Mark S. Germain

Board Member

Do you work at Pluristem Therapeutics?

Does leadership effectively guide Pluristem Therapeutics toward its goals?

Pluristem Therapeutics jobs

Pluristem Therapeutics founders

Name & TitleBio

Shai Meretzki

Founder

Pluristem Therapeutics board members

Name & TitleBio

Yaky Yanay

Board Member

CEO and President at Pluristem Therapeutics (Nasdaq, TASE: PSTI) - Spearheading the development of placenta-based regenerative therapies for unmet medical needs.

Mr. Zami Aberman

Executive Chairman

Mr. Zami Aberman is a Chairman and Chief Executive Officer at PLURISTEM THERAPEUTICS INC and is based in Israel.

Doron Shorrer Mba, Cpa

Board Member

Doron Shorrer MBA, CPA is a Chairman & Chief Executive Officer at PLURISTEM THERAPEUTICS INC and is based in Aig Israel Insurance Co. Ltd..

Maital Shemesh-Rasmussen

Board Member

Isaac Braun

Board Member

Mark S. Germain

Board Member

Moria Kwiat

Board Member

Rami Avraham Levi

Board Member

Cpa Shorrer

Board Member

Dana Rubin

Board Member

Pluristem Therapeutics executives FAQs

Who is the founder of Pluristem Therapeutics?

Related company executives

Working at related companies

Related company jobs

Most in demand jobs

Companies
Pluristem Therapeutics
Pluristem Therapeutics Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of Pluristem Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pluristem Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Pluristem Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pluristem Therapeutics. The data presented on this page does not represent the view of Pluristem Therapeutics and its employees or that of Zippia.

Pluristem Therapeutics may also be known as or be related to PLURISTEM THERAPEUTICS INC, Pluristem Therapeutics, Pluristem Therapeutics Inc, Pluristem Therapeutics Inc. and Pluristem Therapeutics, Inc.